Arginine vasopressin in advanced cardiovascular failure during the post-resuscitation phase after cardiac arrest

Resuscitation

Volumn 72, Issue 1, 2007, Pages 35-44

  Mayr, Viktoria ^a   Luckner, Günter ^a   Jochberger, Stefan ^a   Wenzel, Volker ^a   Ulmer, Hanno ^b   Pajk, Werner ^a   Knotzer, Hans ^a   Friesenecker, Barbara ^a   Lindner, Karl ^a   Hasibeder, Walter ^c   Dünser, Martin ^d  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Haemodynamics; Heart arrest; Post resuscitation period; Shock; Vasopressin; Vasopressor therapy

Indexed keywords

ADRENALIN; ARGIPRESSIN; BILIRUBIN; HYDROCORTISONE; LACTIC ACID; MILRINONE; NORADRENALIN; VASOPRESSIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INFUSION; FEMALE; HEART ARREST; HEART FAILURE; HUMAN; LABORATORY TEST; LACTATE BLOOD LEVEL; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; OBSERVATION; PH MEASUREMENT; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; SAMPLE SIZE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ARGININE VASOPRESSIN; BILIRUBIN; BLOOD PRESSURE; EPINEPHRINE; FEMALE; HEART ARREST; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOTENSION; INFUSIONS, INTRAVENOUS; LACTATES; MALE; MILRINONE; NOREPINEPHRINE; RESUSCITATION; RETROSPECTIVE STUDIES;

EID: 33845416753     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2006.06.003     Document Type: Article

References (33)

1. Negovsky V.A., and Gurvitch A.M. Post-resuscitation disease-a new nosological entity. Its reality and significance. Resuscitation 30 (1995) 23-27
2. Kern K.B., Hilwig R.W., Rhee K.H., and Berg R.A. Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning. J Am Coll Cardiol 28 (1996) 232-240
3. Laurent I., Monchi M., Chiche J.D., et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40 (2002) 2110-2116
4. Negovsky V.A. The second step in resuscitation-the treatment of the 'post-resuscitation disease'. Resuscitation 1 (1972) 1-7
5. Cerchiari E.L., Safar P., Klein E., Cantadore R., and Pinsky M. Cardiovascular function and neurologic outcome after cardiac arrest in dog. The cardiovascular post-resuscitation syndrome. Resuscitation 25 (1993) 9-33
6. American Heart Association in collaboration with the International Liasion Committee on Resuscitation. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, part 6: advanced cardiovascular life support: section 8: postresuscitation care. Circulation 102 Suppl. I (2000) I166-I171
7. Deantonio H.J., Kaul S., and Lerman B.B. Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol 13 (1990) 982-985
8. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardipulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 (2002) 562-568
9. Geppert A., Zorn G., Karth G.D., et al. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med 28 (2000) 2360-2365
10. Krismer A.C., Wenzel V., Stadlbauer K.H., et al. Vasopressin during cardiopulmonary resuscitation: a progress report. Crit Care Med 32 9 Suppl. (2004) S432-S435
11. Wenzel V., Krismer A., Arntz H.R., Sitter H., Stadlbauer K.H., and Lindner K.H. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 (2004) 105-113
12. Mutlu G.M., and Factor P. Role of vasopressin in the management of septic shock. Intens Care Med 30 (2004) 1276-1291
13. Luckner G., Dünser M.W., Jochberger S., et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 33 11 (2005) 2659-2666
14. Jolly S., Newton G., Horlick E., et al. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 96 (2005) 1617-1620
15. Goris R.J., te Boekhorst T.P., Nuytinck J.K., and Gimbere J.S. Multiple-organ failure. Generalized autodestructive inflammation?. Arch Surg 120 (1985) 1109-1115
16. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
17. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75 (2003) 482-487
18. Landry D.W., Levin H.R., Gallant E.M., Seo S., D'Allessandro D., Oz M.C., and Oliver J.A. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25 (1997) 1279-1282
19. Tsuneyoshi I., Yamada H., Kakihana Y., Nakamura M., Nakano Q., and Boyle III W.A. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29 (2001) 487-493
20. Morales D.L., Gregg D., Helman D.N., et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 69 (2000) 102-106
21. Dünser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
22. Dünser M.W., Mayr A.J., Ulmer H., et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a restrospective analysis. Anesth Analg 93 (2001) 7-13
23. Kern K.B., Heidenreich J.H., Higdon T.A., et al. Effect of vasopressin on postresuscitation ventricular function: unknown consequences of the recent Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Crit Care Med 31 Suppl. 9 (2004) S393-S397
24. Prengel A.W., Lindner K.H., Keller A., and Lurie K.G. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit Care Med 24 (1996) 2014-2019
25. Dünser M.W., Mayr A.J., Stallinger A., et al. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intens Care Med 28 (2002) 746-751
26. Adrie C., Laurent I., Monchi M., Cariou A., Dhainaou J.F., and Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?. Curr Opin Crit Care 10 (2004) 208-212
27. Gardiner S.M., Kemp P.A., March J.E., Woolley J., and Bennett T. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 125 (1998) 1543-1550
28. Castello R., Vaughn M., Dressler F.A., et al. Relation between pulmonary venous flow and pulmonary wedge pressure: influence of cardiac output. Am Heart J 130 (1995) 127-134
29. Dubois M.J., De Backer D., Creteur J., Anane S., and Vincent J.L. Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intens Care Med 39 (2003) 1020-1023
30. Hamada Y., Karjalainen A., Setchell B.A., Millard J.E., and Bygrave F.L. Concomitant stimulation by vasopressin of biliary and perfusate calcium fluxes in the perfused rat liver. Biochem J 281 (1992) 387-392
31. Ballatori N., and Truong A.T. Cholestasis altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine. Mol Pharmacol 38 (1990) 64-71
32. Holmes C.L., Walley K.R., Chittock D.R., Lehman T., and Russell J.A. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intens Care Med 27 (2001) 1416-1421
33. Patel B.M., Chittock D.R., Russell J.A., and Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582